FDA Approves Genentech's Kadcyla (Ado-Trastuzumab Emtansine), the...
Feb 22, 2013 | Posted by: roboblogger | Full story: Freshnews
Genentech, a member of the Roche Group , today announced that the U.S. Food and Drug Administration has approved Kadcyla for the treatment of people with HER2-positive metastatic breast cancer who have received prior treatment with Herceptin and a taxane chemotherapy.
|Talk Angela App "Kidnapper Behind the Camera"||3 hr||See me||15|
|Yahoo's search engine leans on Yelp for help||3 hr||ruh roh rabbi||1|
|Boss of eBay John Donahoe suffers 53% slump in ...||6 hr||Philip Cohen||3|
|The Florida special election is tonight. Here a...||7 hr||Cat74||30|
|Most Active Stocks Roundup: 3D Systems, RF Micr...||8 hr||Philip Cohen||1|
|Supportive eBay Shareholders Emerge from the Wo...||9 hr||Philip Cohen||1|
|Icahn Escalates War of Words With eBay||9 hr||Philip Cohen||1|